Hideto Kuribayashi1, Yuta Urushibata1, Thuy Ha Duy Dinh2, Hirohiko Imai3, Sinyeob Ahn4, Ravi Teja Seethamraju5, Tadashi Isa2, and Tomohisa Okada2
1Siemens Healthcare K.K., Tokyo, Japan, 2Human Brain Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan, 3Kyoto University Graduate School of Informatics, Kyoto, Japan, 4Siemens Medical Solutions, Berkeley, CA, United States, 5Siemens Medical Solutions, Boston, MA, United States
Synopsis
Glucose
concentrations at posterior cingulate cortex in 20 young healthy subjects were
quantitated via detecting H1-α-glucose peak at 5.23 ppm in 1H MRS at
7T. The spectra were analyzed using
LCModel with data excluding a range of the residual water peak using PPMGAP
parameter, which simply corrected baselines around the H1-α-glucose peak distorted
from the tail of the residual water peak.
The mean glucose concentration was estimated to be 1.0 mM via both
sequences. Cramer-Rao lower bounds of
fitting H1-α-glucose peak were significantly smaller in the semi-LASER (mean: 33.1
%) than those in the short-TE STEAM (49.8 %).
INTRODUCTION
Cerebral glucose
has been measured using 1H MRS.
The glucose peaks in the range of 3-4 ppm are analyzed using spectral
analysis software like LCModel. To fit such
weak peaks overlapped with other high-concentrated metabolite peaks, the prior
knowledge about an intensity ratio to others (e.g., three big methyl peaks) is
usually required. Even if the glucose
peaks are fitted, it is difficult for glucose and taurine to quantitate
separately due to the spectral pattern similarity.1
H1-α-glucose
peak at 5.23 ppm has also been measured at 4T2-3 and 7T4-5
which overcome the low sensitivity. Because
the H1-α-glucose peak is free of spectral overlap, the detection of the H1-α-glucose
has a potential of the accurate quantification of cerebral glucose
concentration. However, if the water
signal is poorly suppressed, the H1-α-glucose peak and surrounding baselines
would be overlapped with the residual water peak. Hence, a proper baseline correction is important
to fit the low-SNR H1-α-glucose peak. In
this study, the H1-α-glucose peak was analyzed using LCModel with data excluding
a range of the residual water peak, and the effects into the baseline around
the H1-α-glucose peak were observed.METHODS
This study was
approved by an institutional review board, and written informed consent was
obtained from subjects. The 20 healthy subjects
(aged 20-24 years) were scanned on an investigational whole-body 7T scanner (MAGNETOM
7T, Siemens Healthcare, Erlangen, Germany).
A single-channel transmit, and 32-channel receive head coil (Nova
Medical, MA, USA) was used. Siemens investigational
prototype sequence of MPRAGE for T1 anatomical imaging was utilized
to position an MRS voxel at the posterior cingulate cortex (27 mL) in the
mid-sagittal plane on the images. B0
shimming was achieved using FASTESTMAP6 (Siemens investigational prototype
sequence). B1 amplitude was
adjusted for the MRS voxels.
MR spectra were acquired using Siemens investigational
prototype sequences of semi-LASER (TR/TE = 6500-8000/32 ms, signal average =
96, scan time = 11-13 min) and short-TE STEAM (TR/TE/TM = 5700-7280/5/45 ms,
signal average = 128, scan time = 12-15.5 min) with VAPOR water suppression7
and outer volume suppression. Identical MRS parameters were RF
transmitter offset = 4.2 ppm, spectral width = 6 kHz, data points = 2048. The TRs were
determined as the shortest values under SAR limitation. Water spectra in the MRS voxels were
acquired too.
Spectra were analyzed using LCModel
(version 6.3-1L). A semi-LASER basis set
was developed in-house. Basis sets only for
the doublet of the H1-α-glucose were generated to quantitate glucose
concentration via the peak. Eddy current
correction8 and water-scaling for quantification9 were performed
using the water spectra. The analysis
window was 0.2-6.0 ppm with the gaps of 4.20-5.00 ppm and 4.47-5.00 ppm in the semi-LASER
and the short-TE STEAM, respectively, to exclude the residual water peak from
the analysis using PPMGAP parameter.
Baseline correction for glucose quantification via the H1-α-glucose peaks
was evaluated using residuals (the acquired spectrum minus the fit) in 5.03-5.43
ppm. The precision of quantification was
evaluated using Cramer-Rao lower bounds (CRLB, %SD). The SNR was calculated with the fit peak
height divided by the SD of the residuals (i.e., baseline-corrected noises) in
0.2-0.6 ppm. The spectra with the SNR of
the H1-α-glucose higher than 3, which is an acceptable value for estimating a detection
limit in analytical chemistry guideline,10 were evaluated for
glucose quantification. Statistical
analysis was conducted, and a P < 0.05 was considered to be statistically significant.RESULTS
Figure 1 shows the
spectra acquired from one representative subject and analyzed using PPMGAP. The insets of the figure 1 shows that the H1-α-glucose
peaks are fitted using the generated basis-sets. Figure 2 shows the spectra in the range of
4.0-6.0 ppm analyzed with and without PPMGAP.
The insets of the figure 2 shows averages and SDs of the residuals
around the H1-α-glucose peak analyzed with (blue) and without (black) PPMGAP. Evaluating with the averaged residuals, the
errors of baseline fitting in the right-hand side near the water peak are
reduced with PPMGAP to the level of those of fitting the H1-α-glucose peak. Evaluating with the SDs of the residuals, the
errors of baseline fitting among the subjects are reduced in the semi-LASER
with PPMGAP.
Results
from the spectral analysis are shown in Table 1. The mean and detection limit of glucose
concentrations were estimated to be 1.0 mM and 0.6 mM, respectively, via both
sequences. The CRLBs of fitting the H1-α-glucose
peak were significantly smaller in the semi-LASER (33.1 %) than those in the
short-TE STEAM (49.8 %). The water peaks
were significantly better suppressed in the short-TE STEAM than those in the
semi-LASER. DISCUSSION
Inadequate water
suppression distorted the baseline around the H1-α-glucose peak. The distortions were severe in the semi-LASER
due to poor water suppression. The
averaged residuals in the semi-LASER had a peak at 5.08 ppm, which would be
formed with the sum of multiple components including the tail of the residual water peak. Excluding data of the residual water peak with
PPMGAP corrected the baseline distortion and reduced the variation among the
subjects. The post-processing approach will
simplify the scanning operation without the optimization of water suppression
and improve the quantification of cerebral glucose concentration via the H1-α-glucose
peak detection.Acknowledgements
The authors thank Dr.
Lana G Kaiser (University of California, Berkeley) to provide the semi-LASER
basis set, Dr. Gerald R Moran (Siemens Healthcare Canada) to provide the
prototype FASTESTMAP sequence, Dr. Tobias Kober (Siemens Healthcare GmbH) to provide
the prototype MPRAGE sequence and Mr. Koji Yasuda (LA Systems) to support
LCModel.References
- Joers JM, Deelchand DK, Kumar A, et al.
Measurement of hypothalamic glucose under euglycemia and hyperglycemia
by MRI at 3T. J Magn Reson Imaging 2017;45:681-691.
- Gruetter
R, Garwood M, Ugurbil K, Seaquist ER.
Observation of resolved glucose signals in 1H NMR spectra of
the human brain at 4T. Magn Reson
Med 1996;36:1-6.
- Gruetter
R, Ugurbil K, Seaquist ER. Steady-state
cerebral glucose concentrations and transport in the human brain. J Neurochem
1998;70:397-408.
- Fichtner
ND, Henning A, Zoelch N, Boesch C, Kreis R.
Elucidation of the downfield spectrum of human brain at 7 T using
multiple inversion recovery delays and echo times. Magn Reson Med 2017;78:11-19.
- Kuribayashi H, Urushibata Y, Dinh THD, et al. Comparison of semi-LASER and short-TE STEAM
pulse sequences for cerebral glucose quantification via detecting H1-α-glucose peak in 1H MRS at
7T. In: Proc Annual Meeting ISMRM, 2021,
p. 2222.
- Gruetter
R, Tkac I. Field mapping without
reference scan using symmetric echo-planar technique. Magn Reson Med 2000;43:319-323.
- Tkac
I, Starcuk Z, Choi I-Y, Gruetter R. In
vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med 1999; 41:649-656.
- Klose
U. In vivo proton spectroscopy in
presence of eddy currents. Magn Reson
Med 1990;14:26–30.
- Gasparovic
C, Song T, Devier D, et al. Use of
tissue water as a concentration reference for proton spectroscopic
imaging. Magn Reson Med 2006;55:1219–1226.
- Guidance
for industry. Q2B Validation of
analytical procedures: Methodology.
International council for harmonization of technical requirements for
pharmaceuticals for human use.
(1996) https://www.fda.gov/media/71725/download